logo

For the Inventor, By the Inventor

Fairfax Station, VA, United States of America

Omrix Biopharmaceuticals Inc.


USPTO Granted Patents = 108



Trademarks = 1

Forward Citations = 472

Loading Chart...
Loading Chart...

69 inventors (with patents filed for the assignee):

goldMedal Israel Nur (55 out of 64 patents)

silverMedal Erez Ilan (31 out of 33 patents)

bronzeMedal Liliana Bar (23 out of 28 patents)

4.  Sivan Doron (17 out of 17 patents)

5.  Roberto Meidler (14 out of 16 patents)

6.  Yair Pilpel (13 out of 13 patents)

7.  Nadav Orr (13 out of 13 patents)

8.  Ronen Eavri (13 out of 14 patents)

9.  Ashley DeAnglis (12 out of 20 patents)

10.  Moti Meron (12 out of 13 patents)

11.  Yuri Zherdev (11 out of 11 patents)

12.  Omri Faingold (11 out of 12 patents)

13.  Dwayne Lee Looney (10 out of 30 patents)

14.  Yotam Gurman (9 out of 10 patents)

15.  Oleg Belyaev (9 out of 9 patents)


Core Competencies:
Thrombin Compositions
Wound Dressing
Fibrin Sealant
Antimicrobial Compositions
Hemostatic Mixtures
Protein Stabilization
Sample Preparation Devices
Curable Fluid Applications
Glycolytic Compounds
Syringe Assemblies
Thrombin Microcapsules
Plasma-Supplemented Formulations

108 patents:

1. 12351843 - Method for purifying and quantifying thrombin and its degradation polypeptides (2025-07-08),
2. 12311015 - Stable liquid thrombin compositions (2025-05-27),
3. 12203947 - Device and process for sample preparation (2025-01-21),
4. 12133868 - Viral inactivated biological mixture (2024-11-05),
5. 12082796 - Device and method for the application of a curable fluid composition to a bodily organ (2024-09-10),
6. 11993797 - Thrombin solution and methods of use thereof (2024-05-28),
7. 11986489 - Method of treating a disease using a glycolytic dependent compound (2024-05-21),
8. 11957798 - Wound dressing and a method for producing the same (2024-04-16),
9. 11957324 - Device and method for preparing and administering one-component fibrin sealant (2024-04-16),
10. 11938165 - Stable pharmaceutical foam (2024-03-26),
11. 11918629 - Low concentrated protein compositions for preventing tissue adhesion (2024-03-05),
12. 11911448 - Stable liquid thrombin compositions (2024-02-27),
13. 11857564 - Hemostatic composition comprising an anion exchanger and a calcium salt (2024-01-02),
14. 11712495 - Hemostatic mixture of cellulose-based short and long fibers (2023-08-01),
15. 11697006 - Powder dispensing applicator (2023-07-11),
Omrix Biopharmaceuticals Inc. is a biotechnology company specializing in developing, manufacturing, and marketing surgical and hemostatic products. Dedicated to improving patient outcomes, Omrix focuses on providing innovative solutions for surgeons and healthcare professionals. Their portfolio includes products for surgical bleeding control and tissue repair in various medical fields. With a commitment to innovation and patient care, Omrix aims to contribute to the advancement of surgical techniques and ultimately improve the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

108 Patents

#5 in Fairfax Station, VA

#64 in Virginia

#3,407 in US

#7,062 in the World

...
Fairfax Station, VA, United States of America

Omrix Biopharmaceuticals Inc.

Forward Citations = 472

69 inventors:

goldMedal Israel Nur (55 out of 64 patents)

silverMedal Erez Ilan (31 out of 33 patents)

bronzeMedal Liliana Bar (23 out of 28 patents)

4.  Sivan Doron (17 out of 17 patents)

5.  Roberto Meidler (14 out of 16 patents)

Please report any incorrect information to support@idiyas.com
Loading…